Pasteur Institut News Today

A molecule produced naturally in the gut can help prevent and even treat influenza, according to a study reported in the journal Gut Microbes by researchers at the State University of Campinas (UNICAMP) in São Paulo state, Brazil, and Pasteur Institut in Lille, France.

Prof Mary Horgan and Prof Sam McConkey to head groups on emerging health threats and vaccine development

The Lille-based teams under Professors François Pattou (Lille University, Lille University Hospital, INSERM and the Institut Pasteur in Lille) and Philippe Preux (Lille University and INRIA) have developed a digital medical device which can predict the expected weight loss of an individual patient in the 5 years following their bariatric surgery. Based on 7 variables as well as artificial intelligence, it was developed from a cohort of 1,500 patients operated on and monitored for more than 15 y...

When Deltacron was first reported, researchers dismissed it. Now, evidence shows that the recombinant variant is very real but not a cause for concern.

The Lao Ministry of Health announced on January 9 that the country has recorded 924 new COVID-19 infections

The Ministry of Health on January 9 reported 30 new Covid-19 cases, 29 of which were imported and all were confirmed to be the Omicron variant.

Ministry of Health and World Health Organisation (WHO) officials in Cambodia urge vigilance as the Kingdom’s first Omicron community case has been detected. In a press release on January 9, the ministry said the man, a 23-year-old Cambodian from the capital’s Russey Keo district, tested positive with subsequent lab confirmation of the variant.

Real-Time Genomic Surveillance for SARS-CoV-2 Variants of Concern, Uruguay - The Maravi Post

Better Outfitted and Screened Viral Vectors Are Safer and More Effective Better Outfitted and Screened Viral Vectors Are Safer and More Effective Adeno-associated virus (AAV) vectors are the leading vectors for gene delivery. Two AAV-based gene therapies have been approved by the U.S. Food and Drug administration, and dozens more are in clinical trials. However, AAV vectors pose challenges including costly manufacture, high percentages of empty capsids, and safety issues associated with high-d...

Very few mutations will materially alter the course of the pandemic.  “Among the numerous SARS-CoV-2 variants that have been detected, only a very small proportion are of public health concern,” US government advisor Anthony Fauci wrote in an open letter published last week in the JAMA science journal. The English, South African and Brazilian variants, however, all share a particular mutation — named N501Y — that is consequential. The mutation occurs on the virus’ spike protein, whic...